Menu

Filters

  • Result Found In

Flu Vaccine NOW AVAILABLE
Flu Diagnosis

Flu Diagnosis

Flu Diagnose

Influenza (Flu) Antiviral Diagnosis to Quickly Identify the Source of Symptoms

Fast, accurate diagnosis is key to developing a treatment plan for any condition and disease—and flu is no exception. Without the right diagnostic tools, however, it is very hard to distinguish flu from other viral or bacterial causes of respiratory illnesses. And if it's an influenza-like illness (ILI), it won't necessary respond to antivirals used to treat flu.

If It's Not COVID-19, It Could Be Flu!

A patient with symptoms of respiratory illness who tests negative for COVID-19 may have still have the flu—which is why flu testing remains important, especially among groups receiving fewer vaccinations than last year, including children and pregnant women.¹

Henry Schein Medical offers a robust portfolio of flu tests that can be administered and read at the point of care. With rapid results in minutes, rather than hours and days, it may be possible for you to:

  • Chart the right course of treatment
  • Reduce the severity and durations of symptoms and conditions
  • Improve the patient experience
  • Increase your caseload due to the reduction in time spent with tested patients

Our flu test portfolio includes readers and lateral flow options.


Flu Test Readers

BD Veritor™ Plus System - Henry Schein Medical
BD Veritor™ Plus System

This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. The system can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), and group A strep while the patient is still on site, which can enable faster decision-making for an earlier intervention opportunity.

  • Faster access to test results
  • Improved workflow
  • Improved traceability
  • Modularity
  • Connectivity
Abbott DIGIVAL™ - Henry Schein Medical
Abbott DIGIVAL™

Accurately reads and interprets lateral flow tests in just seconds, delivering automated, objective results in any health-care setting. It is a camerabased instrument that will detect the presence of, and identify a completed lateral flow assay, analyze the intensity of the test and control line, and display the results (positive, negative, or invalid) on the color touch screen.

  • Small footprint
  • 4.3" color touch screen
  • Barcode scanner and optional printer
  • QC lockout features
  • Workflow flexibility
  • ReadNOW or Walkaway capabilities
  • Data storage: 1000 patient test results
  • 100 QC test results
  • 50 calibration check test results
  • Accurate, objective, rapid results
  • Bidirectional connectivity
Sekisui Acucy™ - Henry Schein Medical
Sekisui Acucy™

The Acucy™ Influenza A&B Test on the Acucy™ System provides clinicians flexibility in workflow and accurate, standardized results for improved patient care.

  • CLIA waived
  • "Read Now" or "Walk Away" modes
  • Results within 15 minutes
  • Nasal and nasopharyngeal swab types
  • Includes 2 additional tests for quality-control testing

Lateral Flow Flu Tests

Henry Schein OneStep™ + Ultra Flu Test - Henry Schein Medical
Henry Schein OneStep™ + Ultra Flu Test

Intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal and nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.

  • CLIA waived
  • Results in 10 minutes
  • Sensitivity (A/B): 90.3%/88%
  • Specificity (A/B): 96.7%/99.2%
  • For use with nasal and nasopharyngeal swab specimens
QuickVue® Influenza Test - Henry Schein Medical
QuickVue® Influenza Test

An immunoassay for detecting influenza types A and B. Three simple steps with results in 10 minutes or less. Color-coded procedure card helps demonstrate each step of test. Kit contains positive and negative controls, and stores at room temperature.

  • Detects both A and B types of influenza
  • CLIA waived
  • Sensitivity (A/B): 94%/70%
  • Specificity (A/B): 90%/97%
  • Color-coded procedure card helps demonstrate each step of the test
  • No instrumentation needed
  • Results in 10 minutes or less
  • Room-temperature storage
OSOM® Ultra Flu A&B Test - Henry Schein Medical
OSOM® Ultra Flu A&B Test

An in vitro, rapid qualitative test that detects influenza type A and B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection.

  • CLIA waived
  • Simple procedure: easy-to-use, premeasured extraction buffer for swab samples and unique cassette design for streamlined workflow
  • Confident results: easy, differentiated interpretation of results in 10-15 minutes